Genflow Bisciences – Interim Report 2026-09
29 September, 2026
Genflow Meets Primary Endpoint in SLAB Clinical Trial – Detailed Trial Results to be Presented at the Animal Longevity Summit 2026
09 September, 2026
Progress Across Sirt6 Patent Portfolio
03 August, 2026
Company to present at Animal Longevity Summit 2026
18 June, 2026
GM Notice June 2026
04 June, 2026
GM Proxy Form June 2026
04 June, 2026
Genflow Biosciences – Final Results May 2026
30 May, 2026
Exercise of Warrants and Issue of Equity
08 May, 2026